D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$484M |
| 2 |
Walt Disney
DIS
|
+$398M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$324M |
| 4 |
GE Aerospace
GE
|
+$187M |
| 5 |
Dell
DELL
|
+$185M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$386M |
| 2 |
PayPal
PYPL
|
+$308M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$278M |
| 4 |
Charter Communications
CHTR
|
+$226M |
| 5 |
Bank of America
BAC
|
+$217M |
Sector Composition
| 1 | Healthcare | 14.49% |
| 2 | Technology | 14.01% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 11.96% |
| 5 | Industrials | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
TrueCar
TRUE
$172M
| $274K | ﹤0.01% |
29,013
+3,416
| +13% | +$32.3K |
|
2202
Banc of California
BANC
$2.65B
| $273K | ﹤0.01% |
15,650
-48,265
| -76% | -$842K |
|
2203
STMicroelectronics
STM
$23B
| $273K | ﹤0.01% |
33,449
-387,700
| -92% | -$3.16M |
|
2204
STAAR Surgical
STAA
$1.37B
| $271K | ﹤0.01% |
28,836
+16,211
| +128% | +$152K |
|
2205
Brink's
BCO
$4.76B
| $270K | ﹤0.01% |
7,292
-32,700
| -82% | -$1.21M |
|
2206
CorVel
CRVL
$4.39B
| $268K | ﹤0.01% |
20,934
-24,657
| -54% | -$316K |
|
2207
Kadant
KAI
$3.75B
| $268K | ﹤0.01% |
5,144
-227
| -4% | -$11.8K |
|
2208
Group 1 Automotive
GPI
$6.09B
| $266K | ﹤0.01% |
4,162
-23,038
| -85% | -$1.47M |
|
|
CALA
2209
DELISTED
Calithera Biosciences, Inc
CALA
| $265K | ﹤0.01% |
4,081
+2,219
| +119% | +$144K |
|
|
GNBC
2210
DELISTED
Green Bancorp, Inc
GNBC
| $265K | ﹤0.01% |
24,200
-8,624
| -26% | -$94.4K |
|
2211
Fidus Investment
FDUS
$754M
| $264K | ﹤0.01% |
+16,757
| New | +$264K |
|
2212
CONMED
CNMD
$1.63B
| $263K | ﹤0.01% |
6,560
-69,008
| -91% | -$2.77M |
|
|
KEM
2213
DELISTED
KEMET Corporation
KEM
| $261K | ﹤0.01% |
73,174
-154,509
| -68% | -$551K |
|
|
KMG
2214
DELISTED
KMG Chemicals Inc
KMG
| $260K | ﹤0.01% |
9,185
-17,123
| -65% | -$485K |
|
2215
Costamare
CMRE
$1.46B
| $259K | ﹤0.01% |
28,290
-610
| -2% | -$5.59K |
|
|
BNCN
2216
DELISTED
BNC Bancorp
BNCN
| $259K | ﹤0.01% |
10,650
-719
| -6% | -$17.5K |
|
2217
Frontline
FRO
$5.02B
| $258K | ﹤0.01% |
35,931
+15,997
| +80% | +$115K |
|
2218
J.M. Smucker
SJM
$11.7B
| $258K | ﹤0.01% |
1,903
-87,740
| -98% | -$11.9M |
|
|
MYOK
2219
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $258K | ﹤0.01% |
+15,819
| New | +$258K |
|
2220
Standex International
SXI
$2.44B
| $257K | ﹤0.01% |
2,766
-24,711
| -90% | -$2.3M |
|
|
ALPN
2221
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $256K | ﹤0.01% |
7,880
-2,771
| -26% | -$90K |
|
|
ADXS
2222
DELISTED
Advaxis, Inc.
ADXS
| $256K | ﹤0.01% |
1,595
-6,653
| -81% | -$1.07M |
|
2223
Hovnanian Enterprises
HOV
$869M
| $254K | ﹤0.01% |
6,020
+3,681
| +157% | +$155K |
|
|
COR
2224
DELISTED
Coresite Realty Corporation
COR
| $254K | ﹤0.01% |
3,431
+340
| +11% | +$25.2K |
|
|
MXPT
2225
DELISTED
MaxPoint Interactive, Inc.
MXPT
| $254K | ﹤0.01% |
28,503
| – | – |
|